Krsnaa Diagnostics Limited (KRSNAA) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Krsnaa Diagnostics Limited stock ₹614, price ₹516, upside +19.1%, quality 41 out of 100. Rating: undervalued. Calculated from audited financials with 16 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Krsnaa Diagnostics Limited
KRSNAA · NSEOnly slightly cheap (16% below fair value), weak company and falling price: meets none of the 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 12, 2026.
How to read this chart
60‑month range ₹355.26 – ₹1,013 · fair‑value band ₹460.69 – ₹767.82 · the ₹515.55 price screens below the ₹614.26 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 12, 2026.
Every Wednesday you see whether Krsnaa Diagnostics is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Krsnaa Diagnostics Limited provides diagnostic services in India.
Show moreShow less
It offers a range radiology services, including computed tomography scans, magnetic resonance imaging, X-rays, and ultrasound and advanced imaging; pathology services, such as laboratory, and home collection and preventive health; and teleradiology and telepathology services.
The company also provides other diagnostics services, such as ophthalmic test, mammography, dental imaging, stress test, dual-energy X-ray absorptiometry scan, and bone mineral density test.
It serves individual patients, government clients, corporate clients, hospitals, clinics, private practitioner, and other healthcare providers. Krsnaa Diagnostics Limited was incorporated in 2010 and is based in Pune, India.
Stock analysis
Krsnaa Diagnostics Limited (KRSNAA) currently trades at ₹515.55, while our model-based Fair Value estimate is ₹614.26, implying the stock looks roughly 16% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ₹844.28 per share, and 8 of the 16 models we run sit above the ₹515.55 price.
Bear case: the Asset-Based group reads lowest at ₹191.90, and 8 of the 16 models stay below the price. Data coverage for this calculation is high.
Scenario range: ₹460.69 (bear) to ₹767.82 (bull), the price of ₹515.55 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 41/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Krsnaa Diagnostics Limited reported revenue of ₹7.7B in FY2026 versus ₹4.6B in FY2022, a compound +14.1%/yr. Reported net income was ₹1.0B in FY2026, compounding +10.4%/yr from FY2022.
Key figures
Market cap ₹16.9B (≈ $180M) Micro · P/E ratio 17.2 · P/S ratio 2.01 · EPS (TTM) ₹29.93 · Dividend yield 0.4% · Net margin 11.6% · Return on equity 10.9% · Return on assets (EBIT) 7.8% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 48 out of 100 (low confidence).
What moves the price
The share trades about 37% below its 52-week high and 9% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −10% fair-value upside, at 19%, KRSNAA screens cheaper than that median.
Fair Value models
All 16 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Watch KRSNAA, get fair value alerts →
Compare Krsnaa Diagnostics Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Diagnostics & Research · 150 stocks
Valuation Multiplesvs Diagnostics & Research median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Return on equity by industry
- Quality Score by industry
- Stock screener with 62 metrics
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Diagnostics & Research stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| WuXi AppTec Co 603259 | ¥144.41 | ¥164.66 | +14% | vs KRSNAA |
| IQVIA Holdings IQV | $265.12 | $291.63 | +10% | vs KRSNAA |
| Illumina, Inc ILMN | $207.01 | $227.71 | +10% | vs KRSNAA |
| Thermo Fisher Scientific Inc TMO | $700.22 | $686.04 | −2% | vs KRSNAA |
| Danaher Corporation DHR | $233.02 | $209.18 | −10% | vs KRSNAA |
| IDEXX Laboratories, Inc IDXX | $704.23 | $496.48 | −30% | vs KRSNAA |
| Lonza Group LONN | CHF 670.20 | CHF 259.80 | −61% | vs KRSNAA |
| Mettler-Toledo International Inc MTD | $1,739 | $655.06 | −62% | vs KRSNAA |
| Agilent Technologies, Inc A | $173.96 | $64.53 | −63% | vs KRSNAA |
| Waters Corporation WAT | $460.25 | $91.26 | −80% | vs KRSNAA |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Krsnaa Diagnostics Limited (KRSNAA) overvalued or undervalued?
What is the fair value of KRSNAA?
What is the quality score of KRSNAA?
What is the price target for Krsnaa Diagnostics Limited (KRSNAA)?
What is the Krsnaa Diagnostics Limited stock forecast for 2026?
What is the revenue of Krsnaa Diagnostics Limited (KRSNAA)?
Does Krsnaa Diagnostics Limited pay a dividend?
How much is the dividend of Krsnaa Diagnostics Limited (KRSNAA) and when is the ex-dividend date?
What is the intrinsic value of Krsnaa Diagnostics Limited (KRSNAA)?
Is Krsnaa Diagnostics Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of KRSNAA?
How much is Krsnaa Diagnostics Limited worth?
What do the bullish and bearish scenarios say about KRSNAA?
What is the P/E ratio of KRSNAA?
How solid is the balance sheet of Krsnaa Diagnostics Limited (KRSNAA)?
How far is KRSNAA from its 52-week high?
Which stocks are comparable to Krsnaa Diagnostics Limited?
Is Krsnaa Diagnostics Limited stock attractive at the current price?
How is the fair value of KRSNAA calculated?
Is it still worth investing in stocks now?
What is the share price of Krsnaa Diagnostics Limited (KRSNAA)?
What should I pay attention to with Krsnaa Diagnostics Limited right now?
Key figures of Krsnaa Diagnostics Limited
How large is the market capitalisation of Krsnaa Diagnostics Limited (KRSNAA)?
What is the P/S ratio of Krsnaa Diagnostics Limited (KRSNAA)?
What are the earnings per share of Krsnaa Diagnostics Limited (KRSNAA)?
What is the dividend yield of Krsnaa Diagnostics Limited (KRSNAA)?
What is the net margin of Krsnaa Diagnostics Limited (KRSNAA)?
What is the return on equity of Krsnaa Diagnostics Limited (KRSNAA)?
What is the EBIT return on assets of Krsnaa Diagnostics Limited (KRSNAA)?
What is the operating margin of Krsnaa Diagnostics Limited (KRSNAA)?
How fast is revenue growing at Krsnaa Diagnostics Limited (KRSNAA)?
How fast are earnings growing at Krsnaa Diagnostics Limited (KRSNAA)?
How much free cash flow does Krsnaa Diagnostics Limited (KRSNAA) generate?
How much net debt does Krsnaa Diagnostics Limited (KRSNAA) carry?
Watch Krsnaa Diagnostics Limited in the live analysis
One click puts Krsnaa Diagnostics Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.